Patent · US Active

Methods and devices for transcervical treatment of endometrial cancer and hyperplasia

US11524146B2 · kind B2 · utility

0Cited by
7References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2020
Grant dateDec 13, 2022
Priority date
Expiry dateOct 7, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1425
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An infusion catheter includes a housing, a proximal shaft assembly, a first distal shaft assembly and a second distal shaft assembly. The housing has one or more inflation ports and one or more infusion ports. The proximal shaft assembly supports a first balloon. The first distal shaft assembly extends distally from the proximal shaft assembly and supports a first distal balloon. The second distal shaft assembly extends distally from the proximal shaft assembly and supports a second distal balloon. The first and second distal shaft assemblies define infusion openings in fluid communication with the one or more infusion ports. The infusion catheter may be inserted into a uterine cavity to occlude tubal ostia and an internal cervical OS of the uterine cavity for sealing the uterine cavity. A therapeutic agent may be delivered through the infusion catheter and into the sealed uterine cavity to treat the uterine cavity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.